Stay updated on Prevnar 13/Pneumovax 23 Safety/Immunogenicity in Adults 50+ Clinical Trial

Sign up to get notified when there's something new on the Prevnar 13/Pneumovax 23 Safety/Immunogenicity in Adults 50+ Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Prevnar 13/Pneumovax 23 Safety/Immunogenicity in Adults 50+ Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page’s revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site release rather than a change to the clinical trial details.
    Difference
    0.1%
    Check dated 2026-04-24T06:17:11.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Page revision updated to v3.5.2, replacing v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:33:02.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    40 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.0, replacing the previous Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T04:52:10.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Revision: v3.4.3 replacing v3.4.2. This appears to be a system/UI update with no changes to the study details presented on the page.
    Difference
    0.1%
    Check dated 2026-03-12T02:48:41.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removal of the general government funding/operating status notice. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T14:09:15.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    A government funding lapse notice banner was added. The site version was updated from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T10:23:59.000Z thumbnail image

Stay in the know with updates to Prevnar 13/Pneumovax 23 Safety/Immunogenicity in Adults 50+ Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Prevnar 13/Pneumovax 23 Safety/Immunogenicity in Adults 50+ Clinical Trial page.